Try
Stevanato Group S.p.A. Ordinary Shares
STVNUnited States
9 filed reports · 444 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
9 reports · Dec 2021 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Annual · 20-FSEC EDGAR | 4 | 2,560 | Dec 2022 to Dec 2025 |
| Interim · 6-KSEC EDGAR | 4 | 136 | Jun 2025 to Jun 2026 |
| Annual · 20-F/ASEC EDGAR | 1 | 483 | Dec 2021 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 6-K | Jun 30, 2026 | Aug 4, 2026 | 48 | Open |
| FY2026 Q1 | 6-K | Mar 31, 2026 | May 7, 2026 | 22 | Open |
| FY2025 | 20-F | Dec 31, 2025 | Mar 4, 2026 | 1,107 | Open |
| FY2025 Q3 | 6-K | Sep 30, 2025 | Nov 6, 2025 | 44 | Open |
| FY2025 Q2 | 6-K | Jun 30, 2025 | Aug 5, 2025 | 22 | Open |
| FY2024 | 20-F | Dec 31, 2024 | Mar 6, 2025 | 472 | Open |
| FY2023 | 20-F | Dec 31, 2023 | Mar 7, 2024 | 473 | Open |
| FY2022 | 20-F | Dec 31, 2022 | Mar 2, 2023 | 508 | Open |
| FY2021 | 20-F/A | Dec 31, 2021 | Apr 5, 2022 | 483 | Open |
Financial data
444 concepts · 3,179 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial420 concepts · 2,727 facts · Dec 2019 to Jun 2026
- Bank loans32 · Dec 2020 to Dec 2025
- Fair value of derivatives financial instruments20 · Dec 2020 to Dec 2025
- Revenue19 · Dec 2019 to Jun 2026
- Cash and cash equivalents14 · Dec 2019 to Dec 2025
- Deferred tax liability asset14 · Dec 2019 to Dec 2025
- Defined benefit obligation at present value14 · Dec 2019 to Dec 2025
- Equity14 · Dec 2019 to Dec 2025
- IFRS 914 · Dec 2019 to Dec 2025
- Lease liabilities14 · Dec 2019 to Dec 2025
- Other provisions14 · Dec 2019 to Dec 2025
- Provision from slow moving and obsolescence14 · Dec 2019 to Dec 2025
- Reserve of cash flow hedges14 · Dec 2019 to Dec 2025
- Trade receivables14 · Dec 2020 to Dec 2025
- Advances To Suppliers12 · Dec 2020 to Dec 2025
- Allowance for doubtful accounts12 · Dec 2020 to Dec 2025
- Assets (IFRS)12 · Dec 2020 to Dec 2025
- Bank Overdrafts And Short-term Loan Facilities12 · Dec 2020 to Dec 2025
- Borrowings12 · Dec 2020 to Dec 2025
- Contract assets gross12 · Dec 2020 to Dec 2025
- Contract liabilities12 · Dec 2020 to Dec 2025
- Cost of Goods and Services Sold12 · Jun 2024 to Jun 2026
- Current assets12 · Dec 2020 to Dec 2025
- Current contract assets (IFRS)12 · Dec 2020 to Dec 2025
- Current contract liabilities (IFRS)12 · Dec 2020 to Dec 2025
Segment16 concepts · 331 facts · Dec 2019 to Dec 2025
- Revenue112 · Dec 2019 to Dec 2025
- Operating Segments30 · Dec 2020 to Dec 2022
- Cost of sales21 · Dec 2019 to Dec 2025
- General and administrative expense (IFRS)21 · Dec 2019 to Dec 2025
- Gross profit (IFRS)21 · Dec 2019 to Dec 2025
- Profit loss from operating activities21 · Dec 2019 to Dec 2025
- Research and development expense (IFRS)21 · Dec 2019 to Dec 2025
- Sales and marketing expense21 · Dec 2019 to Dec 2025
- Other operating income expense19 · Dec 2019 to Dec 2025
- Biopharmaceutical and Diagnostic Solutions12 · Dec 2019 to Dec 2025
- Depreciation amortisation and impairment loss reversal of impairment loss recognised in profit or loss12 · Dec 2022 to Dec 2025
- Depreciation and amortisation expense9 · Dec 2021 to Dec 2023
- Total Assets4 · Dec 2020 to Dec 2023
- Total Liabilities4 · Dec 2020 to Dec 2023
- Total Segments2 · Dec 2021 to Dec 2022
- Number of external customers exceeded 10% group's revenue1 · Dec 2019
Geography6 concepts · 98 facts · Dec 2019 to Dec 2025
- Average foreign exchange rate52 · Dec 2019 to Dec 2025
- Revenue31 · Dec 2019 to Dec 2025
- Operating Segments12 · Dec 2021 to Dec 2022
- Adjustments for current tax of prior period1 · Dec 2021
- Italy1 · Dec 2025
- Tax grants/not taxable items1 · Dec 2022
Product2 concepts · 23 facts · Dec 2019 to Dec 2025
- Revenue22 · Dec 2019 to Dec 2025
- Sale of Residential Flat1 · Dec 2019
Segments
452 factsFigures broken down by business line, region, product or another axis the company reports on.
Segments5 members · 331 facts
- Biopharmaceutical And Diagnostic Solutions137 · Dec 2019 to Dec 2025
- Engineering121 · Dec 2019 to Dec 2025
- Biopharmaceutical And Diagnostic Solutions And Engineering63 · Dec 2019 to Dec 2025
- Engineering segment8 · Dec 2020 to Dec 2023
- Reportable Segments2 · Dec 2021 to Dec 2022
Geographical areas13 members · 98 facts
- Asia Pacific10 · Dec 2019 to Dec 2025
- Europe Middle East And Africa10 · Dec 2019 to Dec 2025
- North America10 · Dec 2019 to Dec 2025
- South America10 · Dec 2019 to Dec 2025
- BR7 · Dec 2019 to Dec 2025
- CH7 · Dec 2019 to Dec 2025
- CN7 · Dec 2019 to Dec 2025
- DK7 · Dec 2019 to Dec 2025
- JP7 · Dec 2019 to Dec 2025
- MX7 · Dec 2019 to Dec 2025
- US7 · Dec 2019 to Dec 2025
- IT6 · Dec 2021 to Dec 2025
- IN3 · Dec 2023 to Dec 2025
Products and services4 members · 23 facts
- High Value Solutions7 · Dec 2019 to Dec 2025
- Other Containment And Delivery Solutions7 · Dec 2019 to Dec 2025
- Revenues From Engineering7 · Dec 2019 to Dec 2025
- Sale Of Residential Flat2 · Dec 2019
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Management discussion (MD&A) commentary71 claims from 2 reports · Dec 2024 to Dec 2025
- Risk-factor changes4 claims from 1 reports · Dec 2025
- Risk factors116 risks from 2 annual reports · 2024 to 2025
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 4, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.